The aim of this quality improvement (QI) project was to improve the uptake and comprehensiveness of bedside cognitive testing amongst liaison psychiatrists over an eight month period.
Problem
The neuropsychiatry liaison team believed we could improve prevailing practice with regards to bedside cognitive testing. It was our opinion that we should be able to offer comprehensive bedside cognitive assessment given the specialist nature of our service.
This was notwithstanding any availability of neuropsychology review for select cases. With this in mind, we audited the team's practice to see if our informal opinions about the possibility of improvement were reflected in real practice. This was with the intention of directly improving the quality of patient assessment.
One further problem is that many of the most common bedside cognitive tools have limitations. The tools available do not necessarily cover all areas of memory and cognition. This extends even to the Addenbrooke's Cognitive Examination (ACE), which is well regarded. We needed to look at this, and make judgements about whether or not tests could be combined to facilitate comprehensive assessment. At the time of this project, the neuropsychiatry liaison team comprised two neuropsychiatry consultants, two higher trainees (one full-time, one half-time), and one full-time core trainee. Junior trainees also have some responsibility to the broader general adult liaison service. The neuropsychiatry team sees cases where there are psychiatric symptoms in combination with a high suspicion of, or actual confirmed, underlying neurological disease. In this context, the team often sees cases where deficits in cognition and memory are key aspects of the presentation. These deficits may be the result of brain injury, or the product of a pseudodementia in the context of underlying psychiatric illness. Brain injury has a myriad of potential aetiologies including the dementias, traumatic injury, stroke, alcohol, or other neurodegenerative, infectious, and inflammatory conditions. It is important to detect, measure, and map any prevailing cognitive deficits so as to help inform impressions regarding diagnosis, daily functioning, prognosis, and potential for engagement in (and the design of) rehabilitation programmes. Serial cognitive measures can also be used to inform judgements regarding response to treatment in cases where the aetiology is reversible. Patients and families want to know how they will be directly affected, and what to expect.
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In the liaison setting, patients have been admitted to hospital owing to active acute medical or surgical illness and they are often quite morbid. Considering this, it is not always feasible to conduct formal neuropsychological testing due to the time and energy required by the patient. In this setting, the team should be able to adapt and conduct a structured yet more tolerable form of bedside cognitive testing. 
Baseline measurement
The baseline measurement looked at all patients referred to the neuropsychiatry inpatient liaison service at St Thomas's Hospital over a six month period (10th November 2014 through 10th May 2015).
The data extracted from the trust's electronic records included: The results were as follows. There were 19 referrals in total, with mean age 56.2 years, 10 (52.6%) being male. Sixteen (84.2%) referrals were suitable for testing although six (37.5%) of these had insurmountable barriers to testing including severity of medical or psychiatric illness, patient refusal, and severe aphasia. Of the 10 able and suitable referrals, all (100%) had either an ACE or MoCA, an ACE being done in 80% (n=8) of these and a MoCA in 20% (n=2). Where applicable, the ACE cognitive subcategories were documented in all (100%) cases. All 10 (100%) had frontal testing, the frontal test sheet being used in 80% (n=8) of these cases.
These results were disseminated to the team by email and face-toface meeting. Following discussion, it was decided that adding additional tests to the current battery of routine tests (e.g. parietal lobe tests) would be too time-consuming and take away from other activities in a busy liaison service. It was therefore decided that further tests would not be conducted routinely, rather only on the basis of individual clinical need.
From this PDSA cycle therefore, the aims for the next cycle were (a) maintenance of improvements in BCT (b) improve the uptake of the frontal test sheet to 100% if possible. PDSA cycle 2: Given the success in PDSA cycle 1, the basic intervention was not changed, rather the same advice was reiterated and redistributed at team meetings, by email, and by individual discussion to address any questions or concerns. The same measures used in PDSA cycle 1 were collected for a month's worth of referrals (July 2015). We predicted we could maintain performance in the uptake of bedside cognitive testing.
The results were as follows. There were 15 referrals in total, with mean age 48.4 years, 10 (66.6%) being male. Eleven (73.3%) were suitable for testing although four (36.4%) of these had insurmountable barriers to testing including severity of medical or 
Lessons and limitations
Although these factors were not objectively measured, there were other competing forces at play which may have impacted on the comprehensiveness of bedside cognitive testing -for example, efficiency of service delivery with time being preferentially dedicated to other aspects of care (e.g. history, mental state examinations, collateral histories, interactions with family and medical teams, psycho-education, mental capacity testing, mental health act assessments, multi-disciplinary meetings). After discussion, this was the reason PDSA cycle 2 did not include further test sheets looking, for example, at parietal lobe function. At the time of writing, there were ongoing departmental discussions about the potential recruitment of a neuropsychiatry specialist nurse who could help facilitate more detailed bedside cognitive testing.
A further limitation is the low numbers of patients in the PDSA cycles. For this reason, the uptake of testing between PDSA cycle 1 and PDSA cycle 2 is unlikely to be statistically significant (the difference between 100% uptake in PDSA cycle 1 and 85.7% in PDSA cycle 2 was just one patient).
It was important to the clinical team that the results of this project were sustainable and that the new approach to bedside cognitive testing became a practical and manageable, mainstream way of working. By the end of this project, the test sheet introduced had become the standard way we conduct bedside cognitive testing in the department. Furthermore, this new way of working was able to withstand significant challenge and the variation in the number of referrals to our service. Due to new referral pathways (particularly with the stroke service), the number of referrals to the neuropsychiatry team tripled (number of patients per month) over the timeframe between baseline measurement and PDSA cycle 2. It was still however possible to improve bedside testing and largely maintain these improvements into PDSA cycle 2. The uptake was not however perfectly maintained (a 100% uptake of ACE or MoCA in PDSA cycle 1, for example, reduced to 85.7% in PDSA cycle 2).
The comprehensiveness of frontal testing using the dedicated new test sheet nonetheless improved from cycle 1 to 2, from 80% to 83.3%.
There is no reason why the methods applied here cannot be applied in other centres, whether in the field of liaison psychiatry or on psychiatric wards where comprehensive bedside cognitive testing is seen as a priority (e.g. older adults inpatient wards where many patients with dementia are admitted). The methods here are therefore generalisable, as are the results if the methods are effectively implemented with consideration given to resources (staff time) and staff priorities.
Conclusion
In this project, careful thought and analysis of a team's existing practices with regards to bedside cognitive testing resulted in clear improvements in the uptake and comprehensiveness of bedside cognitive testing. This was done by the implementation of a formalised frontal lobe test sheet (with constituent tests described in It is the opinion of the author that these results are sustainable within the service and generalisable to other centres trying to improve the uptake and comprehensiveness of their bedside cognitive testing.
